金龍魚(300999.SZ):約1.6265億股限售股將解禁
格隆匯10月12日丨金龍魚(300999.SZ)公佈,公司此次上市流通的限售股份包括首次公開發行前已發行的限售股份487,943股及公司首次公開發行戰略配售限售股份162,163,946股,合計162,651,889股,佔發行後總股本的3%,解除限售股東户數共計21户。此次解除限售股份的限售期為12個月,可上市流通日期為2021年10月15日。
此次解除股份限售的股東請勿在解限期間辦理轉託管、質押式回購等會導致託管單元發生變更的業務,否則可能導致相應股東解除限售失敗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.